Literature DB >> 12718862

Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Raul R Gainetdinov1, Laura M Bohn, Tatyana D Sotnikova, Michel Cyr, Aki Laakso, Alexander D Macrae, Gonzalo E Torres, Kyeong Man Kim, Robert J Lefkowitz, Marc G Caron, Richard T Premont.   

Abstract

Brain dopaminergic transmission is a critical component in numerous vital functions, and its dysfunction is involved in several disorders, including addiction and Parkinson's disease. Responses to dopamine are mediated via G protein-coupled dopamine receptors (D1-D5). Desensitization of G protein-coupled receptors is mediated via phosphorylation by members of the family of G protein-coupled receptor kinases (GRK1-GRK7). Here we show that GRK6-deficient mice are supersensitive to the locomotor-stimulating effect of psychostimulants, including cocaine and amphetamine. In addition, these mice demonstrate an enhanced coupling of striatal D2-like dopamine receptors to G proteins and augmented locomotor response to direct dopamine agonists both in intact and in dopamine-depleted animals. The present study indicates that postsynaptic D2-like dopamine receptors are physiological targets for GRK6 and suggests that this regulatory mechanism contributes to central dopaminergic supersensitivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718862     DOI: 10.1016/s0896-6273(03)00192-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  102 in total

Review 1.  G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Marc G Caron
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

3.  Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D₂ and D₃ Receptors.

Authors:  Maarten E A Reith; Aloke K Dutta; Dana E Selley; Juan Zhen; Tamara Antonio; Joanna C Jacob; David K Grandy
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

4.  Caenorhabditis elegans TRPV channels function in a modality-specific pathway to regulate response to aberrant sensory signaling.

Authors:  Meredith J Ezak; Elizabeth Hong; Angela Chaparro-Garcia; Denise M Ferkey
Journal:  Genetics       Date:  2010-02-22       Impact factor: 4.562

Review 5.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Social context-dependent singing-regulated dopamine.

Authors:  Aya Sasaki; Tatyana D Sotnikova; Raul R Gainetdinov; Erich D Jarvis
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

7.  Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Authors:  Tanya L Daigle; Mark J Ferris; Raul R Gainetdinov; Tatyana D Sotnikova; Nikhil M Urs; Sara R Jones; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2014-04-29       Impact factor: 7.853

8.  GRK-6 mediates FSH action synergistically enhanced by estrogen and the oocyte in rat granulosa cells.

Authors:  Tomoko Miyoshi; Fumio Otsuka; Shunichi Shimasaki
Journal:  Biochem Biophys Res Commun       Date:  2013-04-09       Impact factor: 3.575

9.  Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.

Authors:  Tai-Xiang Xu; Tatyana D Sotnikova; Chengyu Liang; Jingping Zhang; Jae U Jung; Roger D Spealman; Raul R Gainetdinov; Wei-Dong Yao
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

Review 10.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.